GE HealthCare Technologies Inc. (GEHC)
(Delayed Data from NSDQ)
$91.34 USD
+0.52 (0.57%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $91.35 +0.01 (0.01%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth D Momentum C VGM
Fundamental Charts
About Cash from Investing (Quarterly)
The company's quarterly Cash from Investing value is the sum of the company's current quarter cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
GEHC 91.34 +0.52(0.57%)
Will GEHC be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for GEHC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for GEHC
GE HealthCare's Shares Rise After the Launch of Versana Premier
AtriCure Gets CE Mark for EnCompass Clamp, Expands in Europe
GEHC: What are Zacks experts saying now?
Zacks Private Portfolio Services
GE HealthCare Acquires Intelligent Ultrasound's Clinical AI Business
GEHC's MIM Software to Aid Radiation Therapy With Its Latest FDA Nod
InspireMD Gains FDA Premarket Approval for CGuard Prime Carotid Stent
Other News for GEHC
GE HealthCare says major academic medical center adopts Hospital Pulse Tile
GE Healthcare Technologies Inc’s Flyrcado Gains Buy Rating Amid FDA Approval and Revenue Growth Potential
Ex-Dividend Reminder: GE HealthCare Technologies, Revvity and First Busey
IYH: Healthcare Dashboard For October
Jim Cramer Likes Reddit Very Much, Calls Accenture A 'Great Buy'